indications for glp-1 agonists A glimpse of the future: new molecules and GLP1 💡💉 GLP-1 receptor agonists and next-generation

Stringent cost and payer controls are a significant restraint in the GLP-1 drugs market due to the high prices associated with these therapies

doi: 10.1016/S00928674(01)002409 7 SumithranPPrendergastLADelbridgeEPurcellKShulkesAKriketosAet al

A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis

LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling

8 Considerations to reduce the risk of emesis for patients taking GLP-1 or GLP-1/GIP receptor agonist medications would include avoiding or limiting emetogenic agents